Deenan Pillay
#137,120
Most Influential Person Now
Researcher, ORCID id # 0000-0003-2431-244X
Deenan Pillay's AcademicInfluence.com Rankings
Deenan Pillaybiology Degrees
Biology
#9472
World Rank
#12683
Historical Rank
Virology
#219
World Rank
#226
Historical Rank
Microbiology
#506
World Rank
#567
Historical Rank

Download Badge
Biology
Deenan Pillay's Degrees
- Bachelors Biomedical Science University of Oxford
Why Is Deenan Pillay Influential?
(Suggest an Edit or Addition)Deenan Pillay's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Update of the Drug Resistance Mutations in HIV-1. (2008) (2026)
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update (2009) (905)
- Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. (2008) (569)
- Digital technologies in the public-health response to COVID-19 (2020) (539)
- Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study (2020) (367)
- Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis (2012) (365)
- Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. (2011) (361)
- 2011 update of the drug resistance mutations in HIV-1. (2011) (339)
- Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration (2005) (337)
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance (2007) (335)
- Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study (2021) (313)
- Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. (2009) (266)
- Update of the drug resistance mutations in HIV-1: Fall 2005. (2005) (254)
- Update of the drug resistance mutations in HIV-1: Fall 2006. (2006) (250)
- Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. (2005) (246)
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (2017) (239)
- Update of the drug resistance mutations in HIV-1: March 2013. (2013) (237)
- Update of the drug resistance mutations in HIV-1: December 2010. (2010) (234)
- Update of the drug resistance mutations in HIV-1: December 2009. (2008) (231)
- HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy (2004) (222)
- Taking connected mobile-health diagnostics of infectious diseases to the field (2019) (217)
- Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials. (2008) (210)
- Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. (2000) (207)
- Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. (2017) (195)
- Mutation of a Single Residue Renders Human Tetherin Resistant to HIV-1 Vpu-Mediated Depletion (2009) (195)
- Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study (2005) (192)
- Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model (2008) (192)
- Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study (2020) (191)
- Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing (2004) (185)
- Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting (2001) (184)
- Update of the drug resistance mutations in HIV-1: 2007. (2007) (183)
- Transmission of HIV-1 during primary infection: relationship to sexual risk and sexually transmitted infections (2005) (182)
- Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41 (2005) (179)
- 2017 Update of the Drug Resistance Mutations in HIV-1. (2016) (177)
- Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration (2009) (174)
- The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance (2009) (169)
- Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom (2001) (168)
- Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus (2013) (165)
- AN OPEN-LABEL STUDY OF TENOFOVIR IN HIV-1 AND HEPATITIS B VIRUS CO-INFECTED INDIVIDUALS (2002) (161)
- Update of the Drug Resistance Mutations in HIV-1: 2005. (2005) (160)
- Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice (2005) (158)
- Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. (2009) (156)
- Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study (2016) (155)
- Disease-associated XMRV sequences are consistent with laboratory contamination (2010) (154)
- Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approach (2010) (153)
- Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency (2020) (153)
- HIV and hepatitis C coinfection within the CAESAR study (2004) (148)
- High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. (1999) (147)
- 2014 Update of the drug resistance mutations in HIV-1. (2014) (146)
- Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel (2018) (146)
- Update of the drug resistance mutations in HIV-1: Spring 2008. (2008) (142)
- 2015 Update of the Drug Resistance Mutations in HIV-1. (2015) (140)
- Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection (1992) (132)
- Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient (2000) (131)
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa (2006) (130)
- Long-Term Persistence of Primary Genotypic Resistance After HIV-1 Seroconversion (2004) (129)
- Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site (2018) (127)
- Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man (2004) (122)
- Universal Amplification, Next-Generation Sequencing, and Assembly of HIV-1 Genomes (2012) (120)
- The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy (2006) (118)
- Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa (2015) (117)
- Factors Influencing Efavirenz and Nevirapine Plasma Concentration: Effect of Ethnicity, Weight and Co-Medication (2008) (113)
- Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance. (2000) (112)
- PROVISION OF PROGNOSTIC INFORMATION IN IMMUNOCOMPROMISED PATIENTS BY ROUTINE APPLICATION OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS (1993) (110)
- Update of the drug resistance mutations in HIV-1: 2004. (2004) (110)
- Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease (1999) (108)
- Drug resistance mutations in HIV-1. (2003) (108)
- Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent (2006) (108)
- Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count (2007) (106)
- Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals (2009) (106)
- Incidence and impact of resistance against approved antiretroviral drugs (2000) (106)
- Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. (2002) (104)
- Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance. (2001) (101)
- Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts. (2013) (99)
- Persistence of HIV-1 Transmitted Drug Resistance Mutations (2013) (98)
- Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure (2014) (98)
- Persistence of HIV-1 Transmitted Drug Resistance Mutations (2013) (98)
- HIV‐associated central nervous system diseases in the recent combination antiretroviral therapy era (2011) (98)
- Transmission of HIV-1 drug resistance. (2004) (96)
- Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy? (2000) (94)
- Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings (2011) (94)
- Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of Human Immunodeficiency Virus Type 1 (2007) (94)
- Resistance-Associated Mutations in the Human Immunodeficiency Virus Type 1 Subtype C Protease Gene from Treated and Untreated Patients in the United Kingdom (2001) (91)
- The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis (2002) (91)
- Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003 (2005) (88)
- Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa (2017) (87)
- Phylogenetic Studies of Transmission Dynamics in Generalized HIV Epidemics: An Essential Tool Where the Burden is Greatest? (2014) (83)
- Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic (2020) (82)
- Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy. (2000) (80)
- Gag Determinants of Fitness and Drug Susceptibility in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1 (2009) (80)
- Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. (1999) (77)
- Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men (2000) (75)
- Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study (2018) (75)
- Laboratory Guidelines for the Practical Use of HIV Drug Resistance Tests in Patient Follow-Up (2001) (75)
- Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays (2010) (74)
- Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. (2001) (74)
- Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir (2001) (73)
- Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells (2013) (73)
- Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis (2013) (72)
- Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan Africa (2018) (72)
- Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns (2004) (70)
- Estimating HIV-1 drug resistance in antiretroviral-treated individuals in the United Kingdom. (2005) (69)
- Current Patterns in the Epidemiology of Primary HIV Drug Resistance in North America and Europe (2004) (69)
- Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study (2007) (69)
- Use of Real-Time PCR and Fluorimetry To Detect Lamivudine Resistance-Associated Mutations in Hepatitis B Virus (1999) (69)
- Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom (2007) (68)
- Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom (2016) (68)
- Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions (2014) (68)
- Time and Money: The True Costs of Health Care Utilization for Patients Receiving “Free” HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal (2015) (67)
- SOLID ORGAN TRANSPLANTATION IN PATIENTS WITH HIV INFECTION (2001) (67)
- Synonymous genetic polymorphisms within Brazilian human immunodeficiency virus Type 1 subtypes may influence mutational routes to drug resistance. (2004) (67)
- Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children (2007) (66)
- Semen characteristics in HIV-1 positive men and the effect of semen washing. (1997) (65)
- From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa. (2017) (65)
- Phylogenetic insights into regional HIV transmission (2012) (65)
- Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type 1 Integrase (2008) (64)
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. (2010) (64)
- Constructing the cascade of HIV care: methods for measurement (2016) (64)
- Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation. (2003) (64)
- CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK (2009) (63)
- Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. (2000) (63)
- Analysis of Hepatitis B Virus Quasispecies Changes during Emergence and Reversion of Lamivudine Resistance in Liver Transplantation (1999) (62)
- Parvovirus B19 outbreak in a children's ward (1992) (61)
- Poor penetration of the male genital tract by HIV-1 protease inhibitors. (1999) (61)
- Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study (2017) (60)
- Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study (2017) (60)
- Investigation of vesicular rashes for HSV and VZV by PCR (1998) (59)
- Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. (2010) (59)
- THE PROGNOSTIC SIGNIFICANCE OF POSITIVE CMV CULTURES DURING SURVEILLANCE OF RENAL TRANSPLANT RECIPIENTS (1993) (59)
- Persistently high incidence of HIV and poor service uptake in adolescent girls and young women in rural KwaZulu-Natal, South Africa prior to DREAMS (2018) (59)
- World Health Organization/HIVResNet Drug Resistance Laboratory Strategy (2008) (58)
- Prevalence of long‐term BK and JC excretion in HIV‐infected adults and lack of correlation with serological markers (1999) (57)
- Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase (2004) (57)
- Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy. (2000) (57)
- Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study * (2010) (56)
- Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study (2017) (55)
- Effect of population viral load on prospective HIV incidence in a hyperendemic rural African community (2017) (55)
- A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. (1993) (54)
- Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study (2012) (54)
- Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation (2014) (54)
- Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa (2016) (54)
- Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa (2017) (53)
- The HIV-1 Subtype C Epidemic in South America Is Linked to the United Kingdom (2010) (53)
- The prevalence of hepatitis C virus (HCV) infection in HIV‐positive individuals in the UK – trends in HCV testing and the impact of HCV on HIV treatment outcomes (2009) (52)
- PANGEA-HIV: phylogenetics for generalised epidemics in Africa. (2015) (52)
- Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study (2000) (51)
- The Contribution of Viral Genotype to Plasma Viral Set-Point in HIV Infection (2014) (51)
- Minimal variation in T-20 binding domain of different HIV-1 subtypes from antiretroviral-naive and -experienced patients. (2002) (51)
- Diagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reaction (1997) (51)
- Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance. (2008) (50)
- JC virus associated meningoencephalitis in an immunocompetent girl. (1992) (50)
- Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study (2016) (49)
- Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial (2020) (49)
- Cytomegalovirus Infection and Risk of AIDS in Human Immunodeficiency Virus-Infected Hemophilia Patients (1993) (49)
- British HIV Association guidelines for antiretroviral treatment of HIV‐2‐positive individuals 2010 (2010) (48)
- Antiretroviral therapy CNS penetration and HIV-1–associated CNS disease (2011) (48)
- Prediction of response to antiretroviral therapy by human experts and by the EuResist data‐driven expert system (the EVE study) (2010) (48)
- HIV in the UK 1980–2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy (2007) (48)
- Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak (2018) (47)
- The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. (2002) (46)
- A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products. (1998) (46)
- Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. (2010) (46)
- Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis (2019) (46)
- Evolution of Transmitted HIV-1 with Drug-Resistance Mutations in the Absence of Therapy: Effects on Cd4+ T-Cell Count and HIV-1 Rna Load (2006) (46)
- Impact of Drug Resistance-Associated Amino Acid Changes in HIV-1 Subtype C on Susceptibility to Newer Nonnucleoside Reverse Transcriptase Inhibitors (2014) (45)
- High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy (2013) (44)
- Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions. (2009) (44)
- Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (2018) (44)
- When and how to use maraviroc in HIV-infected patients (2009) (44)
- Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998-2000. (2004) (44)
- Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis. (2014) (43)
- Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. (2007) (43)
- Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis (2019) (42)
- Hepatitis B Virus Infection in HIV-Positive Individuals in the UK Collaborative HIV Cohort (UK CHIC) Study (2012) (42)
- Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations. (2003) (42)
- Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc. (2010) (42)
- Optimal use of maraviroc in clinical practice. (2008) (42)
- The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. (2006) (41)
- The dynamics of appearance and disappearance of HIV-1 integrase mutations during and after withdrawal of raltegravir therapy (2009) (41)
- Improving the care of patients with genital herpes (2000) (41)
- Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda (2020) (41)
- Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults (2020) (41)
- Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission. (2015) (41)
- Three Residues in HIV-1 Matrix Contribute to Protease Inhibitor Susceptibility and Replication Capacity (2010) (40)
- Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study (2021) (40)
- Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study (2021) (40)
- The causal effect of childhood measles vaccination on educational attainment: A mother fixed-effects study in rural South Africa (2015) (39)
- Isolation of viruses from stools in stem cell transplant recipients: a prospective surveillance study (2000) (39)
- Towards an ultra-rapid smartphone- connected test for infectious diseases (2017) (38)
- Testing for HIV: concise guidance. (2009) (38)
- Long-term probability of detecting drug-resistant HIV in treatment-naive patients initiating combination antiretroviral therapy. (2010) (37)
- Outcomes in the First Year after Initiation of First-Line Haart among Heterosexual Men and Women in the Uk Chic Study (2011) (37)
- Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. (2001) (37)
- Long‐term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study (2011) (37)
- The Emergence and Epidemiology of Resistance in the Nucleoside-Experienced HIV-Infected Population (2000) (37)
- HIV-1 DRUG RESISTANCE IN HIV-1-INFECTED CHILDREN IN THE UNITED KINGDOM FROM 1998 TO 2004 (2008) (36)
- Assessment of automated genotyping protocols as tools for surveillance of HIV-1 genetic diversity (2006) (36)
- Lessons from countries implementing find, test, trace, isolation and support policies in the rapid response of the COVID-19 pandemic: a systematic review (2021) (36)
- Detection of drug resistance associated mutations in HIV primary infection within the UK. (2000) (36)
- Emergence of a novel subclade of influenza A(H3N2) virus in London, December 2016 to January 2017 (2017) (36)
- Recombinant strains of HIV type 1 in the United Kingdom. (2001) (36)
- Surveillance for CMV infection in orthotopic liver transplant recipients. (1992) (35)
- Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom. (2015) (35)
- Antiviral drug resistance (1996) (35)
- Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa (2016) (35)
- Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines (2020) (34)
- The effect of transmitted HIV-1 drug resistance on pre-therapy viral load (2010) (34)
- Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care (2013) (34)
- HIV phylogenetics (2007) (34)
- Probable Vertical Transmission of SARS-CoV-2 Infection (2020) (34)
- Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial (2015) (34)
- Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters (2004) (34)
- Management of paediatric HIV-1 resistance (2009) (34)
- HIV type 1 in a rural coastal town in Kenya shows multiple introductions with many subtypes and much recombination. (2012) (34)
- Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis (2017) (33)
- HIV resistance and the developing world. (2007) (33)
- Rapid roll out of SARS-CoV-2 antibody testing—a concern (2020) (33)
- The impact of population dynamics on the population HIV care cascade: results from the ANRS 12249 Treatment as Prevention trial in rural KwaZulu‐Natal (South Africa) (2018) (32)
- Preventing Unintended Pregnancy and HIV Transmission: Effects of the HIV Treatment Cascade on Contraceptive Use and Choice in Rural KwaZulu-Natal (2014) (31)
- The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection (2013) (31)
- Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings (2014) (31)
- Determinants of time from HIV infection to linkage-to-care in rural KwaZulu-Natal, South Africa (2017) (31)
- Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa (2016) (31)
- Universal test and treat is not associated with sub‐optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial (2018) (30)
- Hare TRIM5α Restricts Divergent Retroviruses and Exhibits Significant Sequence Variation from Closely Related Lagomorpha TRIM5 Genes (2010) (30)
- Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain. (2013) (30)
- Ethical considerations in global HIV phylogenetic research. (2018) (30)
- Evolution of Antiretroviral Phenotypic and Genotypic Drug Resistance in Antiretroviral-Naive HIV-1-Infected Children Treated with Abacavir/Lamivudine, Zidovudine/Lamivudine or Abacavir/Zidovudine, with or without Nelfinavir (The Penta 5 Trial) (2001) (30)
- Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. (2012) (30)
- HIV‐1 Protease inhibitors: Their development, mechanism of action and clinical potential (1995) (30)
- High HIV incidence and low uptake of HIV prevention services: The context of risk for young male adults prior to DREAMS in rural KwaZulu-Natal, South Africa (2018) (29)
- The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy (2015) (29)
- What is the risk of mortality following diagnosis of multidrug-resistant HIV-1? (2008) (29)
- Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection. (2000) (29)
- Investigation of HIV-1 transmission events by phylogenetic methods: requirement for scientific rigour. (2005) (29)
- Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance (1998) (29)
- A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study (2018) (28)
- The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings. (2013) (28)
- Cervicovaginal HIV-1 Shedding in Women Taking Antiretroviral Therapy in Burkina Faso: A Longitudinal Study (2014) (27)
- Respiratory viruses in adult liver transplant recipients. (1999) (27)
- Using nearly full-genome HIV sequence data improves phylogeny reconstruction in a simulated epidemic (2016) (26)
- The Impact of Different Definitions on the Estimated Rate of Transmitted HIV Drug Resistance in the United Kingdom (2008) (26)
- Time and money: the true costs of health care utilization for patients receiving 'free' HIV/TB care and treatment in rural KwaZulu-Natal. (2015) (26)
- Characterization of HIV type 1 clades in the Caribbean using pol gene sequences. (2003) (26)
- High Prevalence of Hepatitis G Virus in Bone Marrow Transplant Recipients and Patients Treated for Acute Leukemia (1997) (26)
- Evolution of Drug Resistance During 48 Weeks of Zidovudine/Lamivudine/Tenofovir in the Absence of Real-Time Viral Load Monitoring (2010) (26)
- No Evidence of XMRV or Related Retroviruses in a London HIV-1-Positive Patient Cohort (2011) (26)
- Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study (2017) (26)
- Value of routine surveillance cultures for detection of CMV pneumonitis following bone marrow transplantation. (1993) (25)
- BK virus-associated haemorrhagic cystitis in an HIV-infected man. (1994) (25)
- Drug Resistance in Human Immunodeficiency Virus Type-1 Infected Zambian Children Using Adult Fixed Dose Combination Stavudine, Lamivudine, and Nevirapine (2010) (24)
- Impact of the N348I Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1 (2011) (24)
- Management of herpes virus infections following transplantation. (2000) (24)
- The frequency of HIV-I drug resistance mutations among treatment-naïve individuals at a tertiary care centre in south India (2009) (24)
- Audit of endoscopic surveillance biopsy specimens in HIV positive patients with gastrointestinal symptoms. (1993) (24)
- Do gifts increase consent to home-based HIV testing? A difference-in-differences study in rural KwaZulu-Natal, South Africa (2016) (23)
- PANGEA-HIV 2: Phylogenetics And Networks for Generalised Epidemics in Africa (2019) (23)
- Factors influencing lopinavir and atazanavir plasma concentration. (2010) (23)
- Retention in Care Trajectories of HIV-Positive Individuals Participating in a Universal Test-and-Treat Program in Rural South Africa (ANRS 12249 TasP Trial) (2018) (23)
- Ultra-rapid, sensitive and specific digital diagnosis of HIV with a dual-channel SAW biosensor in a pilot clinical study (2018) (23)
- Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment. (2001) (22)
- Deep learning of HIV field-based rapid tests (2021) (22)
- How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact (2016) (22)
- Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? (2008) (22)
- HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom (2010) (21)
- Analysis of HIV‐1 variation in blood and semen during treatment and treatment interruption (2002) (21)
- Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1. (2014) (21)
- HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK (2016) (21)
- A Randomized Controlled Trial of the Value of Phenotypic Testing in Addition to Genotypic Testing for HIV Drug Resistance: Evaluation of Resistance Assays (ERA) Trial Investigators (2005) (21)
- Failure to initiate HIV treatment in patients with high CD4 counts: evidence from demographic surveillance in rural South Africa (2018) (21)
- Understanding Drivers of Phylogenetic Clustering in Molecular Epidemiological Studies of HIV (2014) (20)
- Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression (2016) (20)
- A Randomized Controlled Trial of Genotypic HIV Drug Resistance Testing in HIV-1-Infected Children: The Pera (Penta 8) Trial (2006) (20)
- HIV-1 Full-Genome Phylogenetics of Generalized Epidemics in Sub-Saharan Africa: Impact of Missing Nucleotide Characters in Next-Generation Sequences (2017) (20)
- Global HIV Antiretroviral Drug Resistance: A Perspective and Report of a National Institute of Allergy and Infectious Diseases Consultation. (2017) (20)
- Secondary parvovirus B19 infection in an immunocompromised child. (1991) (20)
- Primary HIV Infection, phylogenetics, and antiretroviral prevention. (2007) (20)
- Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara) (2012) (19)
- The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children (2015) (19)
- The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy (2005) (19)
- Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I (2019) (18)
- Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception (2011) (18)
- Diagnosis of cytomegalovirus infection: a review. (1992) (18)
- Increased detection of the HIV‐1 reverse transcriptase M184V mutation using mutation‐specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance * (2011) (18)
- The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa (2014) (18)
- HIV Type-1 Drug Resistance in Treatment-Naive Patients Monitored Using Minority Species Assays: A Systematic Review and Meta-Analysis (2011) (18)
- Tracking external introductions of HIV using phylodynamics reveals a major source of infections in rural KwaZulu-Natal, South Africa (2018) (18)
- Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study (2017) (17)
- Drug-Resistant HIV-1 in the Semen of Men Receiving Antiretroviral Therapy with Acute Sexually Transmitted Infections (2002) (17)
- Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo (2015) (16)
- Phylogenetic and Demographic Characterization of Directed HIV-1 Transmission Using Deep Sequences from High-Risk and General Population Cohorts/Groups in Uganda (2020) (16)
- Nosocomial transmission of influenza: A retrospective cross‐sectional study using next generation sequencing at a hospital in England (2012‐2014) (2019) (16)
- Antiviral prophylaxis and treatment (excluding HIV therapy). (2002) (16)
- Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring (2012) (16)
- Respiratory virus infections in immunocompromised patients. (1998) (16)
- Genome-Wide Association Study of HIV Whole Genome Sequences Validated using Drug Resistance (2016) (16)
- Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India. (2009) (16)
- Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study (2013) (15)
- The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains (2011) (15)
- A high HIV-1 strain variability in London, UK, revealed by full-genome analysis: Results from the ICONIC project (2017) (15)
- The priorities for antiviral drug resistance surveillance and research. (2007) (15)
- Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study (2013) (15)
- Causes and Consequences of Incomplete HIV RNA Suppression in Clinical Trials (2009) (15)
- Evaluating the extent of potential resistance to pre‐exposure prophylaxis within the UK HIV‐1‐infectious population of men who have sex with men (2012) (15)
- Effect of isolated V118I mutation in reverse transcriptase on response to first-line antiretroviral therapy (2008) (15)
- Chronic Kidney Disease Risk in African and Caribbean Populations With HIV (2018) (15)
- Population Trends in the Prevalence and Patterns of Protease Resistance Related to Exposure to Unboosted and Boosted Protease Inhibitors (2008) (15)
- British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2001) (15)
- The impact of ART initiation on household food security over time. (2017) (15)
- Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group. (1993) (15)
- Longitudinal Trends in the Prevalence of Detectable HIV Viremia: Population-Based Evidence From Rural KwaZulu-Natal, South Africa (2018) (14)
- Determinants of HIV drug resistance mutations in plasma virus after treatment interruption (2005) (14)
- Clinical outcomes after first‐line HIV treatment failure in South Africa: the next cascade of care (2020) (14)
- The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study (2016) (14)
- The Art of HIV Elimination: Past and Present Science. (2015) (14)
- Transient Viral Load Increases in HIV-Infected Children in the UK and Ireland: What do They Mean? (2007) (13)
- Positive and Negative drug Selection Pressures on the N348I Connection Domain Mutation: New Insights from in vivo Data (2010) (13)
- Implementing universal HIV treatment in a high HIV prevalence and rural South African setting – Field experiences and recommendations of health care providers (2017) (13)
- Development and application of a new measure of engagement in out‐patient HIV care (2016) (13)
- Antiviral drug resistance (1996) (13)
- Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa (2017) (13)
- Hepatitis B serological markers and plasma DNA concentrations (2017) (13)
- No evidence for cross-contamination of dried blood spots excised using an office hole-punch for HIV-1 drug resistance genotyping. (2009) (13)
- Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa (2015) (13)
- GBV‐C/HGV coinfection in HIV‐1‐positive men: Frequent detection of viral RNA in blood plasma but absence from seminal fluid plasma (1998) (12)
- Potential impact of early antiretroviral therapy on transmission (2009) (12)
- Impact of early antiretroviral therapy eligibility on HIV acquisition: household-level evidence from rural South Africa (2018) (11)
- HIV Diagnosis at CD4 Count Above 500 Cells/mm3 and Progression to Below 350 Cells/mm3 Without Antiretroviral Therapy (2007) (11)
- Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial. (2007) (11)
- Moderate-to-High Levels of Pretreatment HIV Drug Resistance in KwaZulu-Natal Province, South Africa. (2019) (11)
- Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions (2003) (11)
- Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy. (1999) (11)
- Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART (2018) (11)
- A Rapid Drug Resistance Genotyping Workflow for Mycobacterium tuberculosis, Using Targeted Isothermal Amplification and Nanopore Sequencing (2021) (11)
- Sources of social support and sexual behaviour advice for young adults in rural South Africa (2018) (11)
- Computer-aided interpretation of chest radiography reveals the spectrum of tuberculosis in rural South Africa (2021) (11)
- A Phylogenetic Analysis of Human Immunodeficiency Virus Type 1 Sequences in Kiev: Findings Among Key Populations (2017) (11)
- Dark matter, second waves and epidemiological modelling (2020) (11)
- Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1 (2017) (10)
- No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom (2016) (10)
- The effect of highly active antiretroviral therapy for HIV on the anti‐HCV specific humoral immune response (2004) (10)
- Phylodynamic and phylogeographic patterns of the HIV type 1 subtype F1 parenteral epidemic in Romania. (2012) (10)
- The impact of self-interviews on response patterns for sensitive topics: a randomized trial of electronic delivery methods for a sexual behaviour questionnaire in rural South Africa (2017) (10)
- Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses (2008) (10)
- Prospective cytomegalovirus surveillance in paediatric renal transplant patients (1993) (10)
- List randomization for eliciting HIV status and sexual behaviors in rural KwaZulu-Natal, South Africa: a randomized experiment using known true values for validation (2018) (10)
- BMI and All‐Cause Mortality in a Population‐Based Cohort in Rural South Africa (2020) (10)
- Emergence and control of resistance to antiviral drugs in resistance in herpes viruses, hepatitis B virus, and HIV. (1998) (10)
- Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa (2010) (10)
- The Prevalence of Darunavir-Associated Mutations in HIV-1-Infected Children in the Uk (2012) (10)
- Do HIV treatment eligibility expansions crowd out the sickest? Evidence from rural South Africa (2018) (10)
- The effect of intrinsic stochasticity on transmitted HIV drug resistance patterns. (2010) (10)
- Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up (2012) (10)
- Genital herpes, "the new paradigm". (1999) (10)
- High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia. (1997) (9)
- Management of advanced HIV disease: resistance, antiretroviral brain penetration and malignancies (2006) (9)
- Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance (2012) (9)
- “They have this not care – don’t care attitude:” A Mixed Methods Study Evaluating Community Readiness for Oral PrEP in Adolescent Girls and Young Women in a Rural Area of South Africa (2020) (9)
- HIV drug resistance: genotypic assays and their possible applications. (1998) (9)
- Implications of HIV Drug Resistance on First- and Second-Line Therapies in Resource-Limited Settings: Report from a Workshop Organized by the Collaborative HIV and Anti-HIV Drug Resistance Network (2013) (9)
- Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children – a EuroCoord-CHAIN-EPPICC joint project (2016) (9)
- Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus (1999) (9)
- Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility (2007) (9)
- The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu-Natal, South Africa (2018) (9)
- High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial (2014) (9)
- The HIV-1 protease substitution K55R: a protease-inhibitor-associated substitution involved in restoring viral replication. (2008) (8)
- Linkage to primary care after home-based blood pressure screening in rural KwaZulu-Natal, South Africa: a population-based cohort study (2018) (8)
- Population-Level Decline in BMI and Systolic Blood Pressure Following Mass HIV Treatment: Evidence from Rural KwaZulu-Natal (2016) (8)
- Pervasive and non-random recombination in near full-length HIV genomes from Uganda (2020) (8)
- Hepatitis G virus infection in patients with bleeding disorders (1997) (8)
- Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation (2015) (8)
- A long-term follow-up of hepatitis B vaccination in patients with congenital clotting disorders. (1994) (8)
- UK HIV drug resistance database: background and recent outputs. (2007) (8)
- Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy (2015) (8)
- CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus (2017) (8)
- Aciclovir resistance among Indian strains of Herpes simplex virus as determined using a dye uptake assay. (2007) (8)
- Antiretroviral therapy based HIV prevention targeting young women who sell sex: a mixed method approach to understand the implementation of PrEP in a rural area of KwaZulu-Natal, South Africa (2021) (7)
- Determining the Origins of Human Immunodeficiency Virus Type 1 Drug-resistant Minority Variants in People Who Are Recently Infected Using Phylogenetic Reconstruction (2018) (7)
- From the micro to the macro to improve health: microorganism ecology and society in teaching infectious disease epidemiology (2020) (7)
- Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy (2015) (7)
- Predictors of death, and response to therapy in patients with multi (three)-class drug resistant (MDR) HIV in the UK. (2005) (7)
- Virological response to initial antiretroviral regimens containing abacavir or tenofovir. (2009) (7)
- ‘Dark matter’, second waves and epidemiological modelling (2020) (7)
- An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs (2017) (7)
- HIV viral load: the myth of the undetectable? (2002) (7)
- Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women (2012) (7)
- Quantifying the contribution of different aged men and women to onwards transmission of HIV-1 in generalised epidemics in sub-Saharan Africa: A modelling and phylogenetics approach from the HPTN071 (PopART) trial (2019) (7)
- Characterization of CMVpp65-Specific CD81 T Lymphocytes Using MHC Tetramers in Kidney Transplant Patients and Healthy Participants. Transplantation 2000; 69: 2243. (2000) (7)
- Gender factors influencing participation in the elimination of mother-to-child transmission of HIV program in Uganda under Option B+. (2017) (7)
- Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population (2019) (7)
- Predictive value of the ultrasensitive HIV viral load assay in clinical practice (2000) (7)
- The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial (2020) (7)
- Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy? (2012) (7)
- Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1. (2001) (7)
- Risk factors for viral reactivation following bone marrow transplantation (2005) (7)
- HIV-1 integrase sequence variation and covariation (2007) (6)
- Book review. Antiviral Drug Resistance Ed. by Douglas D. Richman, John Wiley & Sons, Chichester, 1996. (1998) (6)
- Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors are subtype dependent (2004) (6)
- Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV (2019) (6)
- Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection (2010) (6)
- 844. Engagement in HIV Care as an Avenue to Primary Care in Rural South Africa: Results from the Vukuzazi Population Health Platform (2019) (6)
- Effective immunity and second waves: a dynamic causal modelling study. (2020) (6)
- The Role of Phylogenetics as a Tool to Predict the Spread of Resistance (2017) (6)
- Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study (2009) (6)
- Cohort Profile: The Vukuzazi (‘Wake Up and Know Yourself’ in isiZulu) population science programme (2021) (6)
- Single-centre experience of allogeneic haemopoietic stem cell transplant in paediatric patients in Cape Town, South Africa. (2017) (6)
- Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance (2018) (6)
- Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa (2019) (6)
- Computer-aided interpretation of chest radiography to detect TB in rural South Africa (2020) (6)
- The MONARCH intervention to enhance the quality of antenatal and postnatal primary health services in rural South Africa: protocol for a stepped-wedge cluster-randomised controlled trial (2018) (6)
- Updated BHIVA-BASHH Position Statement on PrEP in the UK (2015) (5)
- The impact of HIV-1 subtype on drug resistance. (2001) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- External introductions helped drive and sustain the high incidence of HIV-1 in rural KwaZulu-Natal, South Africa (2017) (5)
- Antiviral Drug Resistance: From the Laboratory to the Patient (1998) (5)
- No effect of test and treat on sexual behaviours at population level in rural South Africa (2019) (5)
- Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women (2014) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- HIV virology, testing and monitoring (2013) (5)
- Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa (2021) (5)
- Can Linear Regression Modeling Help Clinicians in the Interpretation of Genotypic Resistance Data? An Application to Derive a Lopinavir-Score (2011) (5)
- Does pregnancy increase the risk of ART-induced hepatotoxicity among HIV-positive women? (2014) (5)
- Hepatitis G virus (HGV) and lymphoproliferative disorders. (1997) (5)
- The prevalence of reduced zidovudine susceptibility in zidovudine‐naive, antiretroviral‐experienced HIV‐1‐infected patients (2003) (5)
- The impact of structural and functional constraints acting at the nucleic acid level on the evolution of drug resistance in HIV-1 (2006) (5)
- CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the “Treat-All” Era in Rural South Africa: An Interrupted Time Series Analysis (2021) (5)
- The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data (2017) (4)
- Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control (2016) (4)
- Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. (2016) (4)
- “If you are here at the clinic, you do not know how many people need help in the community”: Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat (2018) (4)
- O112 Trends in transmitted HIV drug resistance among non-B subtypes in the UK (2008) (4)
- Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection. (2003) (4)
- Open science communication: The first year of the UK's Independent Scientific Advisory Group for Emergencies (2022) (4)
- Socio-behavioural and community predictors of unsuppressed viral load: multi-level results from a hyper-endemic rural South African population. (2019) (4)
- Pooled specimens for HIV RNA monitoring: cheaper, but is it reliable? (2014) (4)
- Early ART Initiation Improves HIV Status Disclosure and Social Support in People Living with HIV, Linked to Care Within a Universal Test and Treat Program in Rural South Africa (ANRS 12249 TasP Trial) (2020) (4)
- The Association between Detected drug Resistance Mutations and CD4+ T-Cell Decline in HIV-Positive Individuals Maintained on a Failing Treatment Regimen (2018) (3)
- Comparison of five interpretation algorithms for the prediction of protease inhibitor susceptibility in HIV-1 non-B subtypes (2003) (3)
- Limitations of proposed novel trial design. (2012) (3)
- Emergence of drug resistance in hiv-1 infected patients after first-line highly active antiretroviral therapy (haart): a systematic review of clinical trials (2008) (3)
- Does antiretroviral therapy use affect the accuracy of HIV rapid diagnostic assays? Experience from a demographic health and surveillance site in rural South Africa☆☆☆ (2020) (3)
- Exploring plasma-virus-derived gag-protease interrelationships in drug resistance and fitness landscape (2007) (3)
- Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda (2014) (3)
- Effective immunity and second waves: a dynamic causal modelling study (2020) (3)
- Antiretroviral drug resistance (2011) (3)
- Taking connected mobile-health diagnostics of infectious diseases to the field (2019) (3)
- A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada (2017) (3)
- Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda (2014) (3)
- P407 ‘MTV shuga’: mass media communication, HSV2 and sexual health in adolescent girls and young women in rural south africa (2019) (3)
- HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy (2021) (2)
- ARHAI: antiviral resistance. (2012) (2)
- Improving the Validity of Mathematical Models for HIV Elimination by Incorporating Empirical Estimates of Progression Through the HIV Treatment Cascade (2018) (2)
- Mapping nevirapine and efavirenz resistance using Bayesian networks of HIV-1 pol sequences of subtypes A, B, C, F and G (2005) (2)
- Synonomous genetic changes within subtype FHIV-1 may influence mutational routes to drug resistance (2003) (2)
- A Continuous Quality Improvement Intervention to Improve Antenatal HIV Care Testing in Rural South Africa: Evaluation of Implementation in a Real-World Setting (2020) (2)
- A randomized controlled trial of the value of phenotypic testing in addition to genotypic testing for HIV drug resistance (2005) (2)
- Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors (2015) (2)
- Prevalence of drug resistance in untreated HIV-1-infected individuals in low- and middle-income countries: a systematic review and meta-analysis (2011) (2)
- Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring (2011) (2)
- Independent SAGE replies to The BMJ (2021) (2)
- Genomic Characteristics and Clinical Impact of the Emergent SARS-CoV-2 B.1.1.7 Lineage in North Central London, November to December 2020 (2021) (2)
- Working Party Report Management of herpes virus infections following transplantation A Report from the British Society for Antimicrobial Chemotherapy Working Party* on Antiviral Therapy (2000) (2)
- What is the drug resistance mutational infectious burden in an HIV-1 prevalent cohort and the relationship to incidence of transmitted resistance? (2006) (2)
- Interactions between nevirapine resistance mutations and NRTI resistance mutations (2005) (2)
- Hepatic Dysfunction in a Population of Antibody–Deficient Patients: Prevalence, Aetiology and Outcome of PCR Screening for Hepatitis C and G Viruses (1999) (2)
- Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting. (2010) (2)
- Caring for a patient with rabies: implications of the Milwaukee protocol for infection control and public health measures. (2017) (2)
- Entry into care following universal home-based HIV testing in rural KwaZulu-Natal, South Africa : the ANRS TasP 12249 cluster-randomized trial (2015) (2)
- Utilisation of HIV-1 subtype specific consensus sequences to explore treatment related mutational patterns within and between subtypes (2005) (2)
- The impact of transmitted drug resistance on time to CD4 < 350 cells/ml (2002) (2)
- HIV testing and monitoring (2001) (2)
- Resistance tests: what do clinical trials tell us? (2002) (2)
- Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance (2019) (2)
- Pitfalls of Single Measurement Screening for Diabetes and Hypertension in Community-Based Settings (2021) (2)
- Cytomegalovirus excretion after bone marrow transplantation cannot be predicted from the pre‐transplant level of IgG antibodies (1991) (2)
- Development of a novel application for visualising infectious diseases in hospital settings (2017) (2)
- Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non-B subtypes, in the absence of viral load monitoring, in the DART Study (NORA substudy). (2009) (2)
- Selection of resistance following first-line anti-retroviral regimens among HIV-1 subtypes (2005) (2)
- Monitoring of antiretroviral therapy in low-resource settings – Authors' reply (2008) (2)
- Body mass index and all-cause mortality in a population-based cohort in rural South Africa (2020) (1)
- Incidence of transmitted anti-retroviral drug resistant HIV may be rising in the UK (2000) (1)
- Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial (2016) (1)
- P1 Assessing the role of treatment adherence in a clinical setting (2000) (1)
- HIV Treatment Substantially Decreases Hospitalization Rates: Evidence From Rural South Africa. (2018) (1)
- Pregnancies among women seen for HIV-clinical care - predictors and trends over time (2012) (1)
- Factors determining efficacy of HIV-1 drug resistance genotyping from dried blood spots within an internally-controlled assay system (2007) (1)
- Genomesand Assembly of HIV-1 Universal Amplification, Next-Generation (2014) (1)
- O111 Global impact of HIV drug resistance (2008) (1)
- Erratum: Antiretroviral drug concentrations in semen of HIV-infected men: Differential penetration of indinavir, ritonavir and saquinavir (Journal of Antimicrobial Chemotherapy (2001) vol. 48 (351-354)) (2002) (1)
- O14.6 Mafrica: zenzele, a mobile-phone enabled HIV testing and linkage to care pathway for young people in rural south africa (2019) (1)
- Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness (2021) (1)
- Correction to: Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa (2022) (1)
- Influence of subtype and treatment on genetic profiles of HIV-1 reverse transcriptase and protease: do they act independently in predicting position-specific mutation probabilities in non-subtype B sequences? (2002) (1)
- Bayesian graphical models in the analysis of HIV drug resistance data from the UK HIV Drug Resistance Database (2006) (1)
- Pilot scheme for performance assessment of HIV-1 genotypic resistance testing in the UK. (2004) (1)
- Emergence of drug resistance after failure of first-line HAART is associated with intensity of virological monitoring: a systematic analysis of cohort and trial data specifically addressing the WHO public health approach to antiretroviral therapy (2008) (1)
- immunocompetent girl (2007) (1)
- Antiretroviral resistance in the developing world. (2007) (1)
- Audit of HIV RNA quantitation measurements in the West Midlands: a preliminary report (1998) (1)
- Immediate HIV treatment prevents new infections: causal evidence on the real- world impact of immediate versus deferred ART in rural South Africa (2016) (1)
- Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection. Glasgow, United Kingdom. November 7-11, 2010. (2010) (1)
- Universal Test and Treat and the HIV epidemic in rural South Africa ; a community cluster randomized trial (2017) (1)
- Costs and economies of scale in repeated home-based HIV counselling and testing: Evidence from the ANRS 12249 Treatment as Prevention trial in South Africa (2022) (1)
- Assessment of viral diversity during viral rebound in a HIV-1 elite controller (2014) (1)
- Principles of virology (2009) (1)
- HIV diagnosis and antiretroviral therapy (2008) (1)
- Differences in the dynamics of viral rebound and evolution of resistance between CBV/NVP and CBV/ABC (NORA sub study of DART trial) uncovered in the absence of viral load monitoring in real time. (2008) (1)
- Disappointments in the treatment of acute viral infections: what's the problem? (2002) (1)
- Protease inhibitors effectively block cell-to-cell spread of HIV-1 between T cells (2013) (1)
- Detection of cytomegalovirus by a rapid culture system: a comparison of monoclonal antibodies in a clinical setting. (1992) (1)
- Identification of HIV-1 matrix determinants of fitness compensation in a protease inhibitor resistant virus (2009) (1)
- Disability for HIV and Disincentives for Health: The Impact of South Africa's Disability Grant on HIV/AIDS Recovery (2018) (1)
- Long-term probability of detecting HIV drug resistance in drug-naïve patients starting currently recommended first-line combination ART. (2008) (1)
- The Human Retroviruses, Robert C. Gallo, Gilbert Jay (Eds.). Academic Press, New York (1991), 421 (1993) (1)
- ANTIVIRAL DRUGS : FROM DEVELOPMENT TO RESISTANCE (1998) (1)
- Viral reactivation and immune reconstitution following Campath 1H and fludarabine based non-myeloablative conditioning for allogeneic stem cell transplantation compared to Campath-based T cell depletion regimens: A preliminary report. (1999) (1)
- Go local: The key to controlling the COVID-19 pandemic in the post lockdown era (2020) (1)
- UpdateoftheDrugResistanceMutationsinHIV-1: Spring 2008 (2008) (1)
- Decision letter: Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 (2020) (1)
- HIV Infection in a Long-Term Renal Transplant Recipient (1995) (1)
- The Prevalence of Darunavir-Associated Mutations in HIV-1-Infected Children in the Uk (2012) (1)
- learning of HIV field-based rapid tests’ (2021) (1)
- The potential role of minority mutation assays in surveillance of transmitted drug resistance (2009) (1)
- New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings. (2021) (1)
- Measurement of nucleoside analogue triphosphates by enzymatic assay in HIV patients in a clinical setting (2000) (0)
- Phenotypic data to guide selection of reverse transcriptase inhibitors in second-line therapy following extended virological failure in Uganda (2009) (0)
- Viral Infections, Contemporary Issues in Infectious Diseases. K. Root Richard & E. Sande Merle. Pp. 218+20 figs. Edinburgh: Churchill Livingstone; 1992. (1993) (0)
- What's New (1988) (0)
- Additive Antiviral Effects of Lamivudine and α-Interferon in Chronic Hepatitis B Infection (1999) (0)
- Effectiveness of the dolutegravir transition in Uganda: Disco cohort week-24 results (2021) (0)
- O10.2 Impact of HIV-PrEP for female sex workers on community-wide awareness, uptake, and perceptions in a rural-area kwazulu-natal (2019) (0)
- 1 Ethical Considerations in Global HIV Phylogenetic Research (2018) (0)
- Inferring HIV-1 transmission networks and sources of epidemic spread in Africa with deep-sequence phylogenetic analysis (2019) (0)
- Reply to Ambrosioni et al. (2018) (0)
- Reply to Cohen et al. (2016) (0)
- Dynamics of accumulation of drug resistance mutations in the absence of virological monitoring in HIV-1-infected Zambian children using adult Triomune (fixed-dose combination d4T, 3TC and NVP) (2009) (0)
- South Africa - Vukuzazi Machine Learning Chest X-ray project among individuals aged 15 years and above in rural KwaZulu Natal, South Africa, 2018 (2018) (0)
- Seeing our world through the Life Sciences (2014) (0)
- The drug susceptibility and viral fitness of recombinant viruses expressing patient-derived integrase genes are significantly affected by co-evolved multidrug-resistant protease and reverse transciptase genes (2013) (0)
- Combination HIV prevention and the battle of the sexes (2015) (0)
- Title Computer-aided interpretation of chest radiography to detect TB in rural South Africa (2020) (0)
- Prevalence of atypical mutations at codon 215 of HIV-1 reverse transcriptase (2002) (0)
- Transmitted HIV drug resistance: effect of treatment intensification in limiting the epidemic (2005) (0)
- Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failure (2014) (0)
- P012 A process evaluation of an incentivized home-based intervention to test and start (HITS) in rural kwazulu-natal, south africa (2019) (0)
- Infant feeding knowledge and practice vary by maternal HIV status: a nested cohort study in rural South Africa (2020) (0)
- Resistance in the context of Mother-to-Child transmission Mother-to-child transmission of minority HIV-1 drug resistant strains (2005) (0)
- Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations initiating therapy : modelling study and economic analysis (2018) (0)
- Viral Infections. Contemporary Issues in Infectious Diseases (1993) (0)
- Erratum to “Antiviral prophylaxis and treatment (excluding HIV therapy)” (2003) (0)
- Linkage to HIV care and hypertension and diabetes control in rural South Africa: Results from the population-based Vukuzazi Study (2022) (0)
- AIDS therapy, 3rd edition, Dolin, Massur, Saag (Eds.). Churchill Livingstone, Elsevier (2008) (2008) (0)
- Potent HBV therapy and availability of laboratory monitoring fail to abrogate increased risk of death in HBV-HIV-co-infected individuals in the DART study (2011) (0)
- Meningitis and stridor in advanced Human immunodeficiency virus/acquired immune deficiency syndrome (2013) (0)
- Implementation and effectiveness of a linkage to HIV care intervention in rural South Africa (ANRS 12249 TasP trial) (2023) (0)
- It's not enough to test for HIV and treat it - social factors matter too : HIV and AIDS (2016) (0)
- Maternal infections. Part 2: Cytomegalovirus. (1996) (0)
- Imported HIV infection: the danger of stigmatisation (2017) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
- Prevalence and predictors of protease inhibitor (PI) mutations in HIV-infected UK adults treated with ritonavir-boosted lopinavir as their first PI (2011) (0)
- Protease inhibitors are effective at inhibiting cell-to-cell HIV-1 transfer (2013) (0)
- Complex genotypic changes during failure of HBV nucleoside analogue therapy (2003) (0)
- Evidence for rising prevalence of HIV-1 drug resistance in primary infections in the UK (2001) (0)
- Combination antiviral therapy: but which combination, and why? (2000) (0)
- Management of HIV Drug-Resistant Infections (2004) (0)
- CONCISE COMMUNICATION Resistance to Antiviral Drugs in Herpes Simplex Virus Infections among Allogeneic Stem Cell Transplant Recipients: Risk Factors and Prognostic Significance (0)
- Dynamics of emergence and linkage of HIV reverse transcriptase Q151M MDR complex in children within first-line antiretroviral rollout uncovered by single-genome sequencing (2009) (0)
- Drug Resistance Genotypes Predict Response to Amprenavir-Containing Regimens in Highly Drug-Experienced HIV-1-Infected Patients (2002) (0)
- Hepatic Dysfunction in a Population of Antibody‐Deficient Patients: Prevalence, Aetiology and Outcome of PCR Screening for Hepatitis C and G Viruses (1999) (0)
- Identification of the phenotypic, genotypic and fitness correlates of non-B subtype HIV-1 NRTI resistance through longitudinal analysis of children with virological failure in the developing world (2010) (0)
- P34 Failure of sequential nucleoside analogue monotherapy for the treatment of HBV in HIV/HBV co-infected patients (2000) (0)
- Eleventh International Congress on Drug Therapy in HIV Infection (2012) (0)
- Different evolution of resistance uncovered by single-genome sequencing analysis of patients with long-term virological failure during continuous or interrupted antiretroviral therapy (2010) (0)
- HHV-6 and HHV-7 in febrile convulsions of young children (1996) (0)
- Towards an ultra-rapid smartphone- connected test for infectious diseases (2017) (0)
- Antivirals Against AIDS R. E. Unger, J. Kreuter & H. Rubsamen-Waigmann. Marcel Dekker, Inc., New York, NY, 2000.ISBN 0-8427-0358-8. $150.00. (2001) (0)
- Different evolution of resistance uncovered by single genome sequencing (SGS) analysis of patients with long term virological failure during continuous or interrupted therapy. (2010) (0)
- Original articles 98 Seroprevalence and incidence of genital ulcer infections in a rural Ugandan (1999) (0)
- Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV. (1999) (0)
- Leader Genital herpes , “ the new paradigm ” (1998) (0)
- Genome-wide association study of HIV whole genome sequences validated using drug 1 resistance 2 (2016) (0)
- What aff ects the decisions of parents to allow their infant to participate in a therapeutic vaccine trial ? • What enrolment criteria and endpoints should be considered in a therapeutic vaccine trial that targets paediatric patients with HIV ? (2015) (0)
- Implications for Europe of high prevalence of HIV drug resistance in the United States (2002) (0)
- A Replication Plan for “Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomized trial” (2019) (0)
- The HIV-1 protease mutation K55R is associated with the presence of the M461/L mutation (2003) (0)
- P25 The relationship between ARV drug levels, drug resistance, adherence and treatment failure in a routine clinical setting (2000) (0)
- Predicting the effects on resistance of lack of viral load monitoring in resource-limited settings (2008) (0)
- What's New (2000) (0)
- industrial and developing countries with the shared goal of ending the HIV/AIDS pandemic. (2015) (0)
- Antiretroviral Therapy Based Hiv Prevention Targeting Young Female-Sex Workers: A Mixed Method Approach to Understand the Implementation of Prep in a Rural Area of Kwazulu-Natal, South Africa (2020) (0)
- Transacting Functions of Human Retroviruses (1996) (0)
- Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virologic suppression (2017) (0)
- Control of bloodborne viral infections (2009) (0)
- HIV Transmission Dynamics (2016) (0)
- Hu, J. et al. (2018) The impact of lay counselors on HIV testing rates: quasi-experimental evidence from lay counselor redeployment in KwaZulu- (2019) (0)
- The prevalence of hepatitis G virus in high risk patient groups (1997) (0)
- Virus induced enzymes, J. M. Morrison, John Wiley and Sons, Chichester (1991). Hardback, 655 pp. £85.00; $180.85. ISBN 0471 923 397. (1992) (0)
- O5 Genotypic drug‐resistance testing in early HIV infection (2000) (0)
- What's New (2002) (0)
- Estimation of virological residual activity on a regimen of abacavir/zidovudine/lamivudine (ABC/3TC/ZDV). (2010) (0)
- Multidrug resistant HIV and rapid progression of disease reported from New York. (2005) (0)
- Towards an ultra-rapidsmartphone- connected test forinfectious diseases (2017) (0)
- Virological and clinical outcomes in patients with multi (three)-class drug resistant (MDR) HIV in the UK. (2005) (0)
- Publisher Correction: Computer-aided interpretation of chest radiography reveals the spectrum of tuberculosis in rural South Africa (2021) (0)
- Antiviral drug resistance. (1998) (0)
- Combination Antiretroviral Therapy (cART) and Cell-cell spread of Wild-type and Drug-Resistant HIV-1 (2017) (0)
This paper list is powered by the following services:
Other Resources About Deenan Pillay
What Schools Are Affiliated With Deenan Pillay?
Deenan Pillay is affiliated with the following schools: